429 filings
Page 8 of 22
8-K
9mt71kdzq xo
15 Jun 20
Regulation FD Disclosure
9:22am
8-K
rhomfw 7vio6l43rp1
10 Jun 20
Hepion Pharmaceuticals Welcomes Industry Veteran and Drug Development Expert, Dr. Peter Wijngaard, to its Board of Directors
5:04pm
8-K
0ufbh8yxasqef1eb11f9
20 May 20
Hepion Pharmaceuticals Announces Advancement to Fourth Dose Level in Ongoing Multiple Ascending Dose Clinical Study of CRV431
4:35pm
8-K
1nyddvd
19 May 20
Regulation FD Disclosure
9:51pm
8-K
61xkn bhr204u89tke
19 May 20
Other Events
8:12am
8-K
dwfl1 jvr2q
14 May 20
Other Events
4:15pm
8-K
lrpkos82 nk
17 Apr 20
Entry into a Material Definitive Agreement
4:05pm
8-K
jas3qs 15qjh6e0bjof
30 Mar 20
Other Events
4:05pm
8-K
orli2md2
27 Mar 20
Other Events
12:53pm
424B5
3arjgq8b
26 Mar 20
Prospectus supplement for primary offering
9:33pm
8-K
y6m6 sxhshzkc
12 Mar 20
Other Events
8:47am
8-K
8u536vzgj 4rqd
11 Mar 20
Regulation FD Disclosure
4:05pm
8-K
yfykef6o6ud5x8cos5
20 Feb 20
Other Events
9:12am
8-K
dmuq7zya6jnh4lxmc
12 Feb 20
Entry into a Material Definitive Agreement
4:55pm
8-K
ms3l0
12 Feb 20
Hepion Pharmaceuticals Announces Advancement to Third Dose Level in Ongoing Multiple
4:24pm
424B5
4olmq3qv145piae2c
12 Feb 20
Prospectus supplement for primary offering
9:05am
8-K
z9elfrej14ajz81
7 Feb 20
Regulation FD Disclosure
4:46pm